Abstract
A 36-year-old woman was diagnosed with type 3 advanced gastric cancer with multiple liver metastases in March 1992. The patient was treated with systemic chemotherapy of 5'-deoxy-5-fluorouridine and cisplatin. After 4 courses of chemotherapy, the primary lesion responded and the multiple liver metastases disappeared. Therefore, total gastrectomy with perigastric lymphadenectomy and splenic preservation was performed. Two additional courses of the same chemotherapy were administered after the surgery. The patient has been alive without recurrence for 10 years after the curative resection.
Publication types
-
Case Reports
-
English Abstract
-
Review
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / secondary
-
Adenocarcinoma / surgery
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Drug Administration Schedule
-
Female
-
Floxuridine / administration & dosage
-
Gastrectomy*
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary*
-
Lymph Node Excision
-
Lymphatic Metastasis
-
Neoplasm Staging
-
Splenectomy
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / pathology
-
Stomach Neoplasms / surgery
-
Survivors
Substances
-
Floxuridine
-
Cisplatin
-
doxifluridine